EDGAR Filing Documents for 0001437749-19-024112

Form 8-K - Current report:

SEC Accession No. 0001437749-19-024112

Filing Date

2019-12-10

Accepted

2019-12-10 08:44:11

Documents

Period of Report

2019-12-10

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	dffn20191209_8k.htm	8-K	23823
2	EXHIBIT 99.1	ex_166974.htm	EX-99.1	14670
3		slide01.jpg	GRAPHIC	39749
4		slide02.jpg	GRAPHIC	164810
5		slide03.jpg	GRAPHIC	74050
6		slide04.jpg	GRAPHIC	61412
7		slide05.jpg	GRAPHIC	95889
8		slide06.jpg	GRAPHIC	100341
9		slide07.jpg	GRAPHIC	53627
10		slide08.jpg	GRAPHIC	93681
11		slide09.jpg	GRAPHIC	45505
12		slide10.jpg	GRAPHIC	61094
13		slide11.jpg	GRAPHIC	68040
14		slide12.jpg	GRAPHIC	107829
15		slide13.jpg	GRAPHIC	83827
16		slide14.jpg	GRAPHIC	87437
17		slide15.jpg	GRAPHIC	68629
18		slide16.jpg	GRAPHIC	74265
19		slide17.jpg	GRAPHIC	51567
20		slide18.jpg	GRAPHIC	75433
21		slide19.jpg	GRAPHIC	86743
22		slide20.jpg	GRAPHIC	75790
23		slide21.jpg	GRAPHIC	110359
24		slide22.jpg	GRAPHIC	87276
25		slide23.jpg	GRAPHIC	64171
26		slide24.jpg	GRAPHIC	61783
27		slide25.jpg	GRAPHIC	33642
	Complete submission text file	0001437749-19-024112.txt		2695802

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902

Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718

Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)